US Regulators Give Takeda Clearance For £46B Shire Deal
Japanese pharmaceutical giant Takeda said Tuesday that U.S. regulators have signed off on its £46 billion ($60.9 billion) acquisition of Dublin's Shire, the rare disease-focused drugmaker whose purchase has been months in the works....To view the full article, register now.
Already a subscriber? Click here to view full article